Cone Bioproducts is a biomedical company founded in 1970 with its headquarters in the United States. The company focuses on developing, manufacturing, and marketing human plasma/serum products for in vitro diagnostic products. Its product line includes processed human plasma/serum, quality control and calibrators, proficiency test specimens, purified human proteins, and antisera/antibodies.
Cone Bioproducts differentiates itself by delivering exceptional value to its customers through meeting or exceeding expectations of regulatory compliance, supply, performance, and support. The company emphasizes teamwork, efficiency, and effectiveness in accomplishing its mission while managing production costs and maintaining product quality.
The target market includes IVD manufacturers, distributors, proficiency program providers, and other business entities within the company's supply chain. As the company is currently not associated with any disclosed investor or investment, Cone Bioproducts stands as an established player in the biotechnology industry with a focus on delivering high-quality human plasma/serum products for in vitro diagnostic use.